Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113236471> ?p ?o ?g. }
- W2113236471 endingPage "464" @default.
- W2113236471 startingPage "459" @default.
- W2113236471 abstract "Elderly patients may represent an important group when considering new stroke treatments, particularly in developing countries. The aim of this study was to analyze the use of recombinant tissue plasminogen activator (rtPA) in elderly Brazilian patients with acute ischemic stroke. Clinical and neuroimaging parameters at admission, frequency of symptomatic intracranial hemorrhage, and outcome were compared between elderly (≥80 years) and nonelderly (<80 years) stroke patients treated with rtPA in the Porto Alegre Stroke Network. We evaluated 183 nonelderly patients (mean age, 63 ± 12 years) and 55 elderly patients (mean age, 84 ± 3 years). Female sex, hypertension, congestive heart failure, atrial fibrillation, and previous history of stroke or transient ischemic attack were more frequent in the elderly patients. Elderly patients also presented with higher mean systolic blood pressure (P = .03) and National Institutes of Health Stroke Scale (NIHSS) score (P < .0001), whereas the nonelderly patients had a higher serum glucose level (P = .03). The rate of symptomatic intracranial hemorrhage was 10.9% in the elderly patients and 6.6% in the nonelderly patients (P = .28), and a substantial proportion of the elderly patients achieved a favorable outcome (modified Rankin Scale score ≤1) at 90 days, although this proportion was lower than that in the nonelderly patients (42% vs 58%; P = .04). Pooer outcomes were generally seen in elderly patients with an anterior circulation stroke, a higher NIHSS score, hypoattenuation in ≥1/3 lf the middle cerebral artery territory, and an Alberta Stroke Program Early CT score of ≤7 on an initial computed tomography scan. Our results support the administration of intravenous rtPA in selected elderly stroke patients presenting early to the hospital in developing countries. Elderly patients may represent an important group when considering new stroke treatments, particularly in developing countries. The aim of this study was to analyze the use of recombinant tissue plasminogen activator (rtPA) in elderly Brazilian patients with acute ischemic stroke. Clinical and neuroimaging parameters at admission, frequency of symptomatic intracranial hemorrhage, and outcome were compared between elderly (≥80 years) and nonelderly (<80 years) stroke patients treated with rtPA in the Porto Alegre Stroke Network. We evaluated 183 nonelderly patients (mean age, 63 ± 12 years) and 55 elderly patients (mean age, 84 ± 3 years). Female sex, hypertension, congestive heart failure, atrial fibrillation, and previous history of stroke or transient ischemic attack were more frequent in the elderly patients. Elderly patients also presented with higher mean systolic blood pressure (P = .03) and National Institutes of Health Stroke Scale (NIHSS) score (P < .0001), whereas the nonelderly patients had a higher serum glucose level (P = .03). The rate of symptomatic intracranial hemorrhage was 10.9% in the elderly patients and 6.6% in the nonelderly patients (P = .28), and a substantial proportion of the elderly patients achieved a favorable outcome (modified Rankin Scale score ≤1) at 90 days, although this proportion was lower than that in the nonelderly patients (42% vs 58%; P = .04). Pooer outcomes were generally seen in elderly patients with an anterior circulation stroke, a higher NIHSS score, hypoattenuation in ≥1/3 lf the middle cerebral artery territory, and an Alberta Stroke Program Early CT score of ≤7 on an initial computed tomography scan. Our results support the administration of intravenous rtPA in selected elderly stroke patients presenting early to the hospital in developing countries." @default.
- W2113236471 created "2016-06-24" @default.
- W2113236471 creator A5008443906 @default.
- W2113236471 creator A5011370969 @default.
- W2113236471 creator A5016018326 @default.
- W2113236471 creator A5025318935 @default.
- W2113236471 creator A5034467582 @default.
- W2113236471 creator A5066505115 @default.
- W2113236471 creator A5078724958 @default.
- W2113236471 creator A5081451957 @default.
- W2113236471 date "2011-09-01" @default.
- W2113236471 modified "2023-10-17" @default.
- W2113236471 title "Thrombolytic Therapy for Acute Stroke in the Elderly: An Emergent Condition in Developing Countries" @default.
- W2113236471 cites W1911229365 @default.
- W2113236471 cites W1974061194 @default.
- W2113236471 cites W2031263945 @default.
- W2113236471 cites W2050867990 @default.
- W2113236471 cites W2055586130 @default.
- W2113236471 cites W2064403527 @default.
- W2113236471 cites W2085708547 @default.
- W2113236471 cites W2096029390 @default.
- W2113236471 cites W2096283301 @default.
- W2113236471 cites W2098032054 @default.
- W2113236471 cites W2098181957 @default.
- W2113236471 cites W2109907394 @default.
- W2113236471 cites W2114775432 @default.
- W2113236471 cites W2129036957 @default.
- W2113236471 cites W2129257169 @default.
- W2113236471 cites W2133554094 @default.
- W2113236471 cites W2134155944 @default.
- W2113236471 cites W2138595885 @default.
- W2113236471 cites W2139857865 @default.
- W2113236471 cites W2139899738 @default.
- W2113236471 cites W2147552321 @default.
- W2113236471 cites W2148656951 @default.
- W2113236471 cites W2292308933 @default.
- W2113236471 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2010.02.019" @default.
- W2113236471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20813552" @default.
- W2113236471 hasPublicationYear "2011" @default.
- W2113236471 type Work @default.
- W2113236471 sameAs 2113236471 @default.
- W2113236471 citedByCount "17" @default.
- W2113236471 countsByYear W21132364712013 @default.
- W2113236471 countsByYear W21132364712014 @default.
- W2113236471 countsByYear W21132364712015 @default.
- W2113236471 countsByYear W21132364712016 @default.
- W2113236471 countsByYear W21132364712018 @default.
- W2113236471 countsByYear W21132364712019 @default.
- W2113236471 crossrefType "journal-article" @default.
- W2113236471 hasAuthorship W2113236471A5008443906 @default.
- W2113236471 hasAuthorship W2113236471A5011370969 @default.
- W2113236471 hasAuthorship W2113236471A5016018326 @default.
- W2113236471 hasAuthorship W2113236471A5025318935 @default.
- W2113236471 hasAuthorship W2113236471A5034467582 @default.
- W2113236471 hasAuthorship W2113236471A5066505115 @default.
- W2113236471 hasAuthorship W2113236471A5078724958 @default.
- W2113236471 hasAuthorship W2113236471A5081451957 @default.
- W2113236471 hasConcept C126322002 @default.
- W2113236471 hasConcept C127413603 @default.
- W2113236471 hasConcept C164705383 @default.
- W2113236471 hasConcept C1862650 @default.
- W2113236471 hasConcept C2778198053 @default.
- W2113236471 hasConcept C2779161974 @default.
- W2113236471 hasConcept C2780645631 @default.
- W2113236471 hasConcept C2780931571 @default.
- W2113236471 hasConcept C3020199598 @default.
- W2113236471 hasConcept C541997718 @default.
- W2113236471 hasConcept C71924100 @default.
- W2113236471 hasConcept C78519656 @default.
- W2113236471 hasConcept C84393581 @default.
- W2113236471 hasConceptScore W2113236471C126322002 @default.
- W2113236471 hasConceptScore W2113236471C127413603 @default.
- W2113236471 hasConceptScore W2113236471C164705383 @default.
- W2113236471 hasConceptScore W2113236471C1862650 @default.
- W2113236471 hasConceptScore W2113236471C2778198053 @default.
- W2113236471 hasConceptScore W2113236471C2779161974 @default.
- W2113236471 hasConceptScore W2113236471C2780645631 @default.
- W2113236471 hasConceptScore W2113236471C2780931571 @default.
- W2113236471 hasConceptScore W2113236471C3020199598 @default.
- W2113236471 hasConceptScore W2113236471C541997718 @default.
- W2113236471 hasConceptScore W2113236471C71924100 @default.
- W2113236471 hasConceptScore W2113236471C78519656 @default.
- W2113236471 hasConceptScore W2113236471C84393581 @default.
- W2113236471 hasIssue "5" @default.
- W2113236471 hasLocation W21132364711 @default.
- W2113236471 hasLocation W21132364712 @default.
- W2113236471 hasOpenAccess W2113236471 @default.
- W2113236471 hasPrimaryLocation W21132364711 @default.
- W2113236471 hasRelatedWork W2067977631 @default.
- W2113236471 hasRelatedWork W2073453392 @default.
- W2113236471 hasRelatedWork W2222342249 @default.
- W2113236471 hasRelatedWork W2348720246 @default.
- W2113236471 hasRelatedWork W2742831078 @default.
- W2113236471 hasRelatedWork W2887367514 @default.
- W2113236471 hasRelatedWork W2917172139 @default.
- W2113236471 hasRelatedWork W2991829949 @default.
- W2113236471 hasRelatedWork W3119873540 @default.
- W2113236471 hasRelatedWork W4244374061 @default.